Alyeska Investment Group
ARKG icon

Alyeska Investment Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Alyeska Investment Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-83,519
Closed -$7.41M – 711
2021
Q1 		$7.41M Buy
+83,519
New +$8.28M 0.1% 257

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Alyeska Investment Group's ARKG Position: Q2 2021 in Review

Alyeska Investment Group sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 83,519 shares — an estimated $7.41M sold.

Alyeska Investment Group first reported a position in ARKG in Q1 2021 and held it in 1 quarter. The position peaked at $7.41M in Q1 2021. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • Alyeska Investment Group reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 83,519 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $7.41M.
  • Alyeska Investment Group first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 1 quarter.
  • Alyeska Investment Group's ARK Genomic Revolution ETF position peaked at $7.41M in Q1 2021.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on Alyeska Investment Group's 13F filing for Q2 2021, filed 16 Aug 2021.